Decreased interferon-α and interferon-β production in obesity and expression of suppressor of cytokine signaling

Nutrition

Volumn 29, Issue 1, 2013, Pages 207-212

  Teran Cabanillas, Eli ^a   Montalvo Corral, Maricela ^a   Caire Juvera, Graciela ^a   Moya Camarena, Silvia Y ^a   Hernández, Jesús ^a  

^a CENTRO DE INVESTIGACIÓN EN ALIMENTACIÓN Y DESARROLLO   (Mexico)

Author keywords

Interferon; Obesity; Suppressor of cytokine signaling 3; Toll like receptor; Toll like receptor 3

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MOLECULAR PATHOLOGY; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSOR OF CYTOKINE SIGNALING 1 GENE; SUPPRESSOR OF CYTOKINE SIGNALING 3 GENE;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; INTERLEUKIN-6; LIGANDS; MALE; MIDDLE AGED; OBESITY; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TOLL-LIKE RECEPTORS; YOUNG ADULT;

EID: 84870786888     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.04.019     Document Type: Article

References (27)

1. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006, 6:772-783.
2. Moschen A.R., Molnar C., Geiger S., Graziadei I., Ebenbichler C.F., Weiss H., et al. Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor expression. Gut 2010, 59:1259.
3. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87.
4. Fried S.K., Bunkin D.A., Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998, 83:847.
5. Bastard J.P., Maachi M., van Nhieu J.T., Jardel C., Bruckert E., Grimaldi A., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002, 87:2084.
6. Esposito K., Pontillo A., Di Palo C., Giugliano G., Masella M., Marfella R., et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. JAMA 2003, 289:1799.
7. Van Dielen F., Buurman W., Hadfoune M., Nijhuis J., Greve J. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab 2004, 89:4062.
8. Manco M., Fernandez-Real J.M., Equitani F., Vendrell J., Valera Mora M.E., Nanni G., et al. Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab 2007, 92:483.
9. Amar S., Zhou Q., Shaik-Dasthagirisaheb Y., Leeman S. Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci 2007, 104:20466.
10. Moulin C.M., Marguti I., Peron J.P.S., Rizzo L.V., Halpern A. Impact of adiposity on immunological parameters. Arq Bras Endocrinol Metab 2009, 53:183-189.
11. Papathanassoglou E., El-Haschimi K., Li X.C., Matarese G., Strom T., Mantzoros C. Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. J Immunol 2006, 176:7745.
12. Smith A.G., Sheridan P.A., Harp J.B., Beck M.A. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 2007, 137:1236.
13. Fezeu L., Julia C., Henegar A., Bitu J., Hu F., Grobbee D., et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obesity Rev 2011, 12:653-659.
14. Zimmerer J.M., Lesinski G.B., Kondadasula S.V., Karpa V.I., Lehman A., RayChaudhury A., et al. IFN-α-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins. J Immunol 2007, 178:4832.
15. Vlotides G., Sörensen A., Kopp F., Zitzmann K., Cengic N., Brand S., et al. SOCS-1 and SOCS-3 inhibit IFN-α-induced expression of the antiviral proteins 2, 5-OAS and MxA. Biochem Biophy Res Commun 2004, 320:1007-1014.
16. Michaud F., Coulombe F., Gaudreault E., Paquet-Bouchard C., Rola-Pleszczynski M., Gosselin J. Epstein-Barr virus interferes with the amplification of IFNα secretion by activating suppressor of cytokine signaling 3 in primary human monocytes. PloS One 2010, 5:e11908.
17. Pauli E.K., Schmolke M., Wolff T., Viemann D., Roth J., Bode J.G., et al. Influenza A virus inhibits type I IFN signaling via NF-κB-dependent induction of SOCS-3 expression. PLoS Pathogens 2008, 4:e1000196.
18. Loseke S., Grage-Griebenow E., Wagner A., Gehlhar K., Bufe A. Differential expression of IFN-[alpha] subtypes in human PBMC: evaluation of novel real-time PCR assays. J Immunol Methods 2003, 276:207-222.
19. Jia D., Rahbar R., Chan R.W.Y., Lee S.M.Y., Chan M.C.W., Wang B.X., et al. Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling. PloS One 2010, 5:e13927.
20. Gardner E.M., Beli E., Clinthorne J.F., Duriancik D.M. Energy intake and response to infection with influenza. Annu Rev Nutr 2011, 31:353-367.
21. Pothlichet J., Chignard M., Si-Tahar M. Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway. J Immunol 2008, 180:2034-2038.
22. Koeberlein B., Hausen A., Bektas N., Zentgraf H., Chin R., Toan N.L., et al. Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver. Virus Res 2010, 148:51-59.
23. Bjørbæk C., Elmquist J.K., Frantz J.D., Shoelson S.E., Flier J.S. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998, 1:619-625.
24. Mori H., Hanada R., Hanada T., Aki D., Mashima R., Nishinakamura H., et al. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 2004, 10:739-743.
25. Walsh M., Jonsson J., Richardson M., Lipka G., Purdie D., Clouston A., et al. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1. Gut 2006, 55:529.
26. Dagvadorj J., Naiki Y., Tumurkhuu G., Shadat Mohammod Noman A. Tumor necrosis factor augments lipopolysaccharide induced suppressor of cytokine signalling 3 (SOCS 3) protein expression by preventing the degradation. Immunology 2010, 129:97-104.
27. Funaoka Y., Sakamoto N., Suda G., Itsui Y., Nakagawa M., Kakinuma S., et al. Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91. J Virol 2011, 85:5986-5994.